According to foreign media reports, on April 1, global orthopedic giant Stryker announced that it had completed the sale of its US spinal implant business to Viscogliosi Brothers, LLC, a family investment company focusing on the neuromusculoskeletal field.

It is worth noting that the transaction led to the establishment of a new company called VB Spine, LLC (VB Spine), which also marked the official implementation of Stryker's business restructuring plan announced in January this year. Previously, Stryker stated that in addition to the US market, its international spinal implant business will also be gradually divested.

From Stryker's 2024 financial report, it can be seen that its spinal implant business can no longer help the company's revenue. The financial report shows that in 2024, its spinal implant business revenue was US$707 million (a year-on-year decrease of 0.7%), of which the US spinal implant business decreased by 2.1% year-on-year.

The specific financial terms of the transaction were not disclosed. In a statement at the beginning of the year, Stryker pointed out that the divestiture "will enable both parties to focus more on meeting customer and patient needs, and is expected to accelerate business growth and create greater value for all stakeholders."

According to the agreement, after the transaction is completed, VB Spine will, as a strategic partner of Stryker, obtain exclusive use rights to the Mako spinal system and the auxiliary Copilot system for VB Spine's implants in spinal surgery.

Kevin Lobo, Chairman and CEO of Stryker, said, "Through the interventional spine product line, neuromodulation technology platform and enabling technology business, as well as the strategic cooperation with VB Spine, we will continue to be deeply involved in the field of spinal medicine. I sincerely thank the spine business team for their historical contributions and believe that they will continue to create value on the new platform."

It is worth noting that this transaction comes at a time when competition in orthopedic robotics technology is in full swing. The Mako robotics technology retained by Stryker has covered the field of joint replacement. This authorization of VB Spine to use its spinal version of the technology may become an important layout to seize the commanding heights of the market segment.

https://news.yaozh.com/archive/45242.html?u_atoken=c188a3edf6782bf9fc8f66a0b829ed14&u_asig=0a47309317436585067212315e0114